281 related articles for article (PubMed ID: 25802847)
1. Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.
Huang T; Yang J; Cai YD
Biomed Res Int; 2015; 2015():358125. PubMed ID: 25802847
[TBL] [Abstract][Full Text] [Related]
2. Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
Ding J; Huang M; Huang B; Peng X; Wu G; Peng C; Zhang H; Mao C; Wu X
Environ Mol Mutagen; 2022 Aug; 63(7):351-361. PubMed ID: 36161731
[TBL] [Abstract][Full Text] [Related]
3. Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
Shen Y; Pan X; Yang J
J Cell Physiol; 2019 Dec; 234(12):22896-22910. PubMed ID: 31169310
[TBL] [Abstract][Full Text] [Related]
4. Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression.
Zhou B; Guo R
Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31212967
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
[TBL] [Abstract][Full Text] [Related]
6.
Zhang W; Li T; Hu B; Li H
Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
[TBL] [Abstract][Full Text] [Related]
7. Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma.
Grubelnik G; Boštjančič E; Grošelj A; Zidar N
Biomed Res Int; 2020; 2020():8573793. PubMed ID: 32733958
[TBL] [Abstract][Full Text] [Related]
8. Identification of key classification features of early cervical squamous cell carcinoma.
Wang X; Cao A; Hou Z; Li X; Gao B
Comput Biol Chem; 2021 Aug; 93():107531. PubMed ID: 34217008
[TBL] [Abstract][Full Text] [Related]
9. Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.
Sriram KB; Larsen JE; Savarimuthu Francis SM; Wright CM; Clarke BE; Duhig EE; Brown KM; Hayward NK; Yang IA; Bowman RV; Fong KM
PLoS One; 2012; 7(2):e30398. PubMed ID: 22363434
[TBL] [Abstract][Full Text] [Related]
10. Integrative network-based approach identifies key genetic elements in breast invasive carcinoma.
Hamed M; Spaniol C; Zapp A; Helms V
BMC Genomics; 2015; 16 Suppl 5(Suppl 5):S2. PubMed ID: 26040466
[TBL] [Abstract][Full Text] [Related]
11. Role of DNA methylation regulation of miR-130b expression in human lung cancer using bioinformatics analysis.
Wang J; Yu XF; OUYang N; Luo Q; Tong J; Chen T; Li J
J Toxicol Environ Health A; 2019; 82(17):935-943. PubMed ID: 31524549
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma.
Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J
DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870
[TBL] [Abstract][Full Text] [Related]
14. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
[TBL] [Abstract][Full Text] [Related]
15. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
[TBL] [Abstract][Full Text] [Related]
16. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
17. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
18. Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index.
Du Y; Yuan S; Zhuang X; Zhang Q; Qiao T
Dis Markers; 2021; 2021():3766659. PubMed ID: 34504628
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung.
Xia E; Kanematsu S; Suenaga Y; Elzawahry A; Kondo H; Otsuka N; Moriya Y; Iizasa T; Kato M; Yoshino I; Yokoi S
Sci Rep; 2018 Oct; 8(1):15363. PubMed ID: 30337605
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.
Davidson MR; Larsen JE; Yang IA; Hayward NK; Clarke BE; Duhig EE; Passmore LH; Bowman RV; Fong KM
PLoS One; 2010 Sep; 5(9):e12560. PubMed ID: 20838434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
